期刊文献+

小白菊内酯诱导耐药白血病细胞K562/ADR凋亡的研究 被引量:1

Apoptosis of leukemia K562/ADR cell with multidrug resistance induced by parthenolide
下载PDF
导出
摘要 目的初步探讨小白菊内酯(PTL)对耐药白血病细胞K562/ADR细胞增殖和凋亡的影响及其作用机制。方法MTT法及LDH释放法检测小白菊内酯对K562和K562/ADR细胞增殖抑制作用,流式细胞术检测细胞凋亡和细胞内活性氧(ROS)的变化,Western blot法检测凋亡相关蛋白Bax、Bcl-2、caspase-3、caspase-9的表达变化。结果 PTL抑制K562/ADR细胞的增殖,呈剂量依赖,半数抑制浓度(IC50)值分别为(4.36±0.37)μmol.L-1、(10.6±2.81)μmol.L-1。10μmol.L-1PTL作用24 h诱导K562/ADR细胞的凋亡率为(31.21±0.40)%,其IC50值与凋亡率与K562细胞相比差异无显著性(P>0.05)。经10μmol.L-1PTL处理1 h,K562/ADR细胞内ROS增加;处理24 h,Bcl-2与Bax的比值降低、caspase-3、caspase-9酶源蛋白表达降低。用N-乙酰半胱氨酸(NAC)预处理细胞,能抑制细胞ROS水平升高和细胞凋亡。结论 PTL能诱导耐药白血病细胞凋亡,作用机制与其刺激细胞内ROS升高相关。 Aim To explore the effects of parthenolide(PTL) on cell cytotoxicity and the apoptosis of K562/ADR,and its mechanisms.Methods MTT assay and LDH assay was applied to detect the effect of inhibition on K562,K562/ADR for 72 h.The apoptosis rate and reactive oxygen species(ROS) level of cells were examined by flow cytometry.The expression of proteins Bax,Bcl-2,Bax,caspase-3 and caspase-9 were measured by western blot.Results PTL was shown to inhibit the growth of K562/ADR in a dose-dependent manner,with mean IC50 of(4.36±0.37) μmol·L-1,and LC50 of(10.6±2.81) μmol·L-1.The apoptosis rate of K562/ADR was(31.21±0.40)% induced by 10 μmol·L-1 PTL for 24 h,which had no significant difference from those of K562 cell.Increase of ROS levels were shown in K562 and K562/ADR cells after treatment of 10 μmol·L-1 PTL for 1 h.The expression of Bcl-2/Bax,caspase-3 and caspase-9 decreased induces by 10 μmol·L-1 PTL for 24 h.ROS increase and cell apoptosis of K562/ADR could be inhibited by the antioxidant N-acetyl-L-cysteine(NAC) pretreatment.Conclusion PTL induces multidrug resistance cell K562/ADR apoptosis,and its possible mechanism is associated with the ROS increases in the cellular induced by PTL.
出处 《中国药理学通报》 CAS CSCD 北大核心 2012年第12期1736-1740,共5页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 8100137,21072106)
关键词 小白菊内酯 细胞凋亡 活性氧 耐药 白血病 N-乙酰半胱氨酸 parthenolide cell apoptosis ROS drug resistance leukemia NAC
  • 相关文献

参考文献3

二级参考文献18

  • 1程大丽,张淑兰.核转录因子与细胞周期蛋白D1在宫颈癌中的表达及相关研究(英文)[J].中国现代医学杂志,2005,15(13):1935-1937. 被引量:4
  • 2雷瑚仪,赵谢兰.核因子—κB在急性非淋巴细胞性白血病骨髓细胞中的表达及意义[J].中国现代医学杂志,2005,15(23):3586-3588. 被引量:1
  • 3田芳,许培荣,侯卫红,刘红涛,陈奎生,薛乐勋.NF-κB信号通路在食管鳞癌细胞系中的激活[J].肿瘤防治研究,2006,33(1):11-14. 被引量:15
  • 4马武开,张惠臣.解毒化瘀药含药血清对白血病K562/A02细胞耐药逆转作用的研究[J].国际中医中药杂志,2007,29(4):195-197. 被引量:14
  • 5BRAEUER SJ, BUNKER C, MOHR A, et al. Constitutively activated nuclear factor-kappa B, but not induced NF-κB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells [J]. Mol Cancer Res, 2006, 4: 715-728.
  • 6WU JT, KRAL JG. The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy [J]. J Surg Res, 2005, 123: 158-169.
  • 7HARIKRISHNA NAKSHATR1, SUSAN E RICE, POORNIMA BHAT-NAKSHATRI. Antitumor agent parthenolide reverses re- sistance of breast cancer cells to tumor necrosis factor-related apoptosis inducing ligand through sustained activation of c-Jun N-terminal kinase[J]. Oncogene, 2004, 23: 7330-7344.
  • 8MONICA L, GUZMAN, RANDALL M. ROSSI, SUNDAR NEE- LAKANTAN, et al. An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells[J]. BLOOD, 2007, 13: 4427-4435.
  • 9GARCIA-PINERES AJ, LINDENMEYER MT, MERFORT I. Role of cysteine residues of p65/NF-κB on the inhibition by the sesquiterpene lactone parthenolide and N-ethyl maleimide, and on its transactivating potential [.l]. Life Sciences, 2004, 75: 841-856.
  • 10KIM JH, LIU L, LEE SO, et al. Susceptibility of cholangiocarcnoma cells to parthenolide induced apoptosis [J]. Cancer Res, 2005, 65: 6312-6320.

共引文献117

同被引文献9

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部